Compare SKM & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKM | ICLR |
|---|---|---|
| Founded | 1984 | 1990 |
| Country | South Korea | Ireland |
| Employees | N/A | 40100 |
| Industry | Telecommunications Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 13.1B |
| IPO Year | 1999 | 2001 |
| Metric | SKM | ICLR |
|---|---|---|
| Price | $35.59 | $172.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.5M | 632.6K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.41 | N/A |
| Revenue Next Year | $1.85 | N/A |
| P/E Ratio | $31.64 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.66 | $66.57 |
| 52 Week High | $47.18 | $203.91 |
| Indicator | SKM | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 54.22 |
| Support Level | $35.86 | $162.06 |
| Resistance Level | $36.89 | $183.11 |
| Average True Range (ATR) | 0.76 | 5.90 |
| MACD | -0.39 | 0.10 |
| Stochastic Oscillator | 5.10 | 64.61 |
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production, as well as developing e-commerce and internet platform businesses, these were all spun off into the separate SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.